News for Indivior PLC (INVVY)

The U.S. stock market opened Friday, July 25, 2025, with major indexes showing modest gains, continuing a trend that has seen the S&P 500 and Nasdaq

PR NewswireRICHMOND, Va., July 17, 2025 RICHMOND, Va., July 17, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq / LSE: INDV) today announced that it will report

Indivior (INDV) to release Q2 2025 financial results on July 31 at 7:00 a.m. U.S. ET. CEO Joe Ciaffoni to lead a live webcast presentation at 8:00 a.m.

More than $100 billion worth of London-listed companies have announced or executed plans to move to New York in recent years.

Shares of Indivior PLC (INDV) surged 4.02% in mid-day trading on Jul 2. The stock reached an intraday high of $15.38, before settling at $15.25, up from its

Shares of Indivior PLC (INDV) fell 3.21% in mid-day trading on Jun 23. The stock reached an intraday low of $13.45, before recovering slightly to $13.58, do

Shares of Indivior PLC (INDV) fell 3.27% in mid-day trading on Jun 2. The stock reached an intraday low of $12.34, before recovering slightly to $12.44, dow

Key Highlights: Indivior plans to exit the London Stock Exchange to focus on Nasdaq, aligning with its U.S. market priorities. Analysts set a one-year av

The U.S. stock market opened lower on Monday, June 2, 2025, as renewed tensions between the United States and China weighed on investor sentiment. As of early

PR NewswireSLOUGH, England and RICHMOND, Va., June 2, 2025 SLOUGH, England and RICHMOND, Va., June 2, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV)

Indivior PLC (INDV) to cancel its secondary listing on the London Stock Exchange by July 25, 2025. Primary listing on Nasdaq to be maintained, aligning

PR NewswireRICHMOND, Va., May 27, 2025 Seasoned commercial executive with more than 30 years of pharmaceutical experienceRICHMOND, Va., May 27, 2025 /PRNew

Indivior PLC (INDV) appoints Patrick Barry as Chief Commercial Officer, effective June 2, 2025. Barry brings over 30 years of experience in the pharmace

PR NewswireRICHMOND, Va., May 13, 2025 RICHMOND, Va., May 13, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ/LSE: INDV) today announced that it will participate

\nIndivior PLC (INDV) showcases a robust portfolio with products like Sublocade and Suboxone, driving its competitive edge in addiction treatment.Despite a stron

Study shows SUBLOCADE® poses no increased risk during pregnancy. Opioid use during pregnancy spiked 131% from 2010-2017. Research informs treatment

Indivior PLC’s recovery hinges on Sublocade’s momentum and market trends, though risks persist in litigation and earnings. Find out why INDV stock is a hold.

Shares of Indivior PLC (INDV) surged 3.90% in mid-day trading on Apr 25. The stock reached an intraday high of $11.22, before settling at $11.18, up from it

Apr 24, 2025 / 12:00PM GMTOperator Good day and thank you for standing by. Welcome to the Indivior PLC Q1, 2025 Financial results conference call. (Operator Ins